Cabot (CBT)
(Delayed Data from NYSE)
$109.02 USD
+1.19 (1.10%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $109.06 +0.04 (0.04%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$109.02 USD
+1.19 (1.10%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $109.06 +0.04 (0.04%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Zacks News
US Chemical Industry to Stage a Turnaround in 2021: 4 Picks
by Zacks Equity Research
The chemicals industry is set to stage a rebound on the back of positive macroeconomic developments, which makes the space a hotbed for money
US Chemical Industry Set for Strong Rebound in 2021: 5 Picks
by Anindya Barman
The U.S. chemical industry is poised for an upturn next year on a rebound across major end-markets and a recovery in chemical exports.
Here is Why Growth Investors Should Buy Cabot (CBT) Now
by Zacks Equity Research
Cabot (CBT) is well positioned to outperform the market, as it exhibits above-average growth in financials.
The Zacks Analyst Blog Highlights: Bunge, Cabot Corp, International Paper, Neenah and Schnitzer Steel
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Bunge, Cabot Corp, International Paper, Neenah and Schnitzer Steel
3 Chemical Stocks to Benefit from Strength in Housing and Auto
by Sejuti Banerjea
The recovery in manufacturing activity across the world and particularly, in China (one of the largest consumers of chemicals is a positive for the industry and considering the improving prospects, some of these stocks are still going cheap.
Chemical Industry Looking Up: 5 Top Growth Stocks to Scoop Up
by Anindya Barman
A strong rebound in China's economy and recovering manufacturing activities around the world augur well for the chemical industry.
5 Materials Stocks to Make the Most of Economic Recovery
by Zacks Equity Research
U.S. economy is poised for a rebound on positive COVID-19 vaccine developments and hopes of a fiscal stimulus, making it prudent to invest in stocks like Bunge (BG) and Cabot (CBT) from the materials sector.
Markets Hit Record Highs, Promise Further Growth: 5 Top Picks
by Zacks Equity Research
Promising vaccine news and hopes of further fiscal stimulus helped benchmark indexes to close at record highs, making this a prudent time to invest in names like Cabot (CBT) and Forestar (FOR)
Global Chemical Output Leaps as Recovery Continues to Take Hold
by Anindya Barman
A rebound in demand across major end markets has put the wind back in the sails of the chemical industry.
What Makes Cabot (CBT) a Solid Investment Option Right Now
by Zacks Equity Research
Cabot (CBT) benefits from a recovery in demand in automotive and tire markets and the Shenzhen Sanshun Nano acquisition.
New Strong Buy Stocks for November 30th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today.
Top Ranked Value Stocks to Buy for November 30th
by Zacks Equity Research
Here are three stocks with buy rank and strong value characteristics for investors to consider today, November 30th.
Cabot (CBT) Surpasses Earnings and Sales Estimates in Q4
by Zacks Equity Research
Cabot (CBT) saw a rebound in volumes in its Reinforcement Materials segment on a sequential comparison basis in Q4.
Is Cabot (CBT) a Solid Growth Stock? 3 Reasons to Think " Yes "
by Zacks Equity Research
Cabot (CBT) possesses solid growth attributes, which could help it handily outperform the market.
What Makes Cabot (CBT) a New Buy Stock
by Zacks Equity Research
Cabot (CBT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Is Cabot (CBT) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Will Cost Control Aid Helmerich & Payne's (HP) Q4 Earnings?
by Zacks Equity Research
Helmerich & Payne's (HP) cost-reduction efforts are likely to have boosted its fourth-quarter fiscal 2020 earnings and cash flows.
Cabot (CBT) Introduces New Black Masterbatch Formulation
by Zacks Equity Research
Per Cabot (CBT), the Plasblak XP6801D black masterbatch will assist customers to innovate and provide formulation flexibility.
Cabot (CBT) Expands E2C Line With First Product in New Series
by Zacks Equity Research
The latest addition to E2C family of solutions highlights Cabot's (CBT) commitment to assist tire producers reach performance goals.
Cabot (CBT) Issues an Update on Business Results for Q4
by Zacks Equity Research
Cabot's (CBT) margins in the Performance Chemicals unit are expected to be driven by higher volumes in Performance Additives.
Air Products (APD) to Post Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Air Products' (APD) Q4 results are likely to reflect the unfavorable impacts from the coronavirus pandemic and volumes pressure.
Should You Buy Cabot (CBT) Ahead of Earnings?
by Zacks Equity Research
Cabot (CBT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Daqo New Energy (DQ) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Daqo New Energy's (DQ) third-quarter results are expected to reflect the benefits of higher production volumes.
What's in the Cards for Lithium Americas (LAC) Q3 Earnings?
by Zacks Equity Research
Exploration costs related to the Thacker Pass project are likely to have affected Lithium Americas' (LAC) bottom line in the third quarter.
Albemarle (ALB) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Benefits of cost-saving initiatives are expected to get reflected on Albemarle's (ALB) Q3 results.